The Prostate testing for cancer and Treatment (ProtecT) randomized trial currently being conducted by British researchers will hopefully bring clarity to the debate on how to manage prostate-specific antigen- (PSA-) detected clinically localized prostate cancer.

The FDA has provided 510(k) clearance of GE Healthcare's Discovery IQ PET/CT system, the company announced Monday.

The U.S. National Institutes of Health (NIH) has set an initiative in motion that intents to banish a biomedical research bias toward the use of male animal models and cells in preclinical studies.

The 2014 World Molecular Imaging Congress (WMIC) put a spotlight on the basic science and translation of molecular imaging at the World Trade Center in Seoul, South Korea, from Sept. 17-20. Molecular Imaging caught up with three central figures of the 2015 WMIC to find out more about emerging trends in molecular imaging and ways in which the WMIS operates to aid translation of preclinical research to first-in-human trials.

Newly diagnosed breast cancer patients who chose to undergo contralateral prophylactic mastectomy (CPM) did not make the decision based on MRI imaging Breast Imaging Reporting and Data System (BI-RAD) scores, but on a number of factors, according to a study published in the October issue of Radiology. 

A study of digital breast tomosynthesis (DBT) in clinical practice has once again shown a decrease in recall rates with the technology, but also revealed a significant difference in the distribution of the types of abnormalities recalled compared with digital mammography, according to results published online Sept. 22 in Radiology.

Malignant lesions may not be accurately identified using fludeoxyglucose (FDG) PET scans combined with CT for populations with endemic infectious lung disease, according to a study published in  the Sept. 24 issue of JAMA.

Clear Image Devices LLC (CiD) announces the release of a new ultrasound step platform to be used to examine the upper and lower leg for standing venous insufficiency studies.